__NUXT_JSONP__("/drugs/Abemaciclib_Mesylate", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1231930-82-7",chebiId:b,chemicalFormula:b,definition:"The mesylate salt of abemaciclib, an orally available cyclin-dependent kinase (CDK) inhibitor that targets the cyclin D1-CDK4 and cyclin D3-CDK6 cell cycle pathway, with potential antineoplastic activity. Abemaciclib specifically inhibits CDK4 and 6, thereby inhibiting retinoblastoma (Rb) protein phosphorylation in early G1. Inhibition of Rb phosphorylation prevents CDK-mediated G1-S phase transition, thereby arresting the cell cycle in the G1 phase, suppressing DNA synthesis and inhibiting cancer cell growth. Overexpression of the serine\u002Fthreonine kinases CDK4\u002F6, as seen in certain types of cancer, causes cell cycle deregulation.",fdaUniiCode:"KKT462Q807",identifier:"C162507",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C129825","C2185"],synonyms:["ABEMACICLIB MESYLATE",c,"LY-2835219 Methanesulfonate","LY-2835219 methanesulfonate"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FAbemaciclib_Mesylate",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Abemaciclib_Mesylate","","Abemaciclib Mesylate","2021-10-30T13:35:21.813Z")));